Higano C, Saad F, Somer B, et al. A phase III trial of GVAX immunotherapy for prostate cancer versus docetaxel plus prednisone in asymptomatic, castration -resistant prostate cancer. Genitourinary Cancer Symposium 2009; abstract LBA 150. Androgen suppression with prostate GVAX and cyclophosphamide J1265 Johns Hopkins University 58 of 68 J1265 PROT (Vers) 1.4 113012 30. Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and se rum of prostatic cancer patients. Anticancer Res 1987; 7: 927- 935. 31. Israeli RS, Powell CT, Corr JG, et al. Expression of the prostate -specific membrane antigen. Cancer Res 1994; 54: 1807 -1811. 32. Jaffee EM, Hruban RH, Biedrzycki B, et al. Novel allogeneic granulocyte- macrophage c olony - stimulating f actor –secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immune activation. J Clin Oncol 2001; 19: 145 -156.